VRS
TVRD

Virginia Retirement Systems’s Tvardi Therapeutics TVRD Stock Holding History

Virginia Retirement Systems’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-289
Closed -$97.3K – 1248
2022
Q3 		$97.3K Buy
+289
New +$105K ﹤0.01% 1114
2022
Q1 		$467K Sell
1,067
-458
-30% -$188K ﹤0.01% 868
2021
Q4 		$669 Hold
1,525
– – ﹤0.01% 774
2021
Q3 		$848K Sell
1,525
-197
-11% -$98.8K 0.01% 647
2021
Q2 		$885K Buy
1,722
+641
+59% +$406K 0.01% 689
2021
Q1 		$845K Buy
1,081
+320
+42% +$219K 0.01% 715
2020
Q4 		$415K Buy
+761
New +$399K ﹤0.01% 908

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virginia Retirement Systems's TVRD Position: Q4 2022 in Review

Virginia Retirement Systems sold out of Tvardi Therapeutics (TVRD) in Q4 2022, closing a stake of 289 shares — an estimated $97.3K sold.

Virginia Retirement Systems first reported a position in TVRD in Q4 2020 and held it in 7 quarters. The position peaked at $885K in Q2 2021. 160 funds tracked by Wall St. Rank hold TVRD as of Q4 2022.

  • Virginia Retirement Systems reported no remaining Tvardi Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 289 Tvardi Therapeutics shares in Q4 2022, an estimated $97.3K.
  • Virginia Retirement Systems first reported a position in Tvardi Therapeutics in Q4 2020 and held it in 7 quarters.
  • Virginia Retirement Systems's Tvardi Therapeutics position peaked at $885K in Q2 2021.
  • 160 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2022.

Based on Virginia Retirement Systems's 13F filing for Q4 2022, filed 17 May 2023.